Wednesday 28 April 2021
MSN Labs launches generic Favipiravir tablets for COVID-19 treatment
MSN Laboratories on Wednesday said it has launched the generic version of antiviral drug Favipiravir in 800 mg strength for treating mild and modera
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment